Incidencia acumulada de eventos cardiovasculares adversos mayores en pacientes con enfermedad del tronco de la arteria coronaria izquierda asociada con enfermedad coronaria multivascular tratados
Contenido principal del artículo
Resumen
Analizar la incidencia acumulada de eventos cardiovasculares adversos a cinco años en la población de pacientes con enfermedad del tronco de la arteria coronaria izquierda asociada con enfermedad coronaria multivascular tratados mediante intervención coronaria percutánea e implante de stent.
Detalles del artículo
Sección
Cómo citar
Referencias
Stone P, Goldschlager N. Left main coronary artery disease: review and appraisal. Cardiovasc Med 1979;4:165-77.
DeMots H, Rosch J, McAnulty J, et al. TCT-317: The SYNTAX trial at 3 Years: A Global Risk Approach to Identify Patients With 3-Vessel &/or Left Main Stem Disease Who Could Safely & Efficaciously Be Treated With Percutaneous Co- ronary Intervention Part 1: The Randomized Population. J Am Coll Cardiol 2011.
Farooq V, Serruys PW, Vrancx P, Brugaletta S, et al. TCT- 211: The SYNTAX trial at 3 Years: A Global Risk Approach to Identify Patients With 3-Vessel &/or Left Main Stem Disease Who Could Safely & Efficaciously Be Treated With Percutaneous Coronary Intervention Part 2: The All-Comers SYNTAX Population. J Am Coll Cardiol 2011.
Park DW, Kim YH, Yun SC, Song HG, et al. Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting. J Am Coll Cardiol 2011;57:2152-9.
Wijns W, Kolh P, Danchin N, Di Mario C, et al. Guidelines on myocardial Revascularization: The Task Force on Myocardial Revascularisation of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501-55.
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH: 2011 ACCF/AHA/ SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guide- lines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58:44-122.
Chieffo A, Magni V, Latib A, et al: 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience. J Am Coll Cardiol Intv 2010;3:595-601.
Chaitman BR, Fisher LD, Bourassa MG, Davis K, Rogers WJ, Maynard C, Tyras DH, Berger RL, Judkins MP,Ringqvist I, Mock MB, Killip T. Effect of coronary bypass surgery on sur- vival patterns in subsets of patients with left main coronary artery dise ase. Report of the Collaborative Study in Coro- nary Artery Surgery (CASS). Am J Cardiol 1981;48:765-77. Cutlip DE, Windecker S, Mehran R, et al.
Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51.
AlaideCh, Emanuele M, et al. The DELTA Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Treatment. J Am Coll Cardiol Intv 2012;5:718-27.
Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-27.